New female condom tested against market leader

NCT ID NCT06821152

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a new female condom called Miss Liberty against the existing FC2 female condom. 235 women aged 18-45 used each condom five times in a random order. Researchers measured breakage, slippage, and other failures to see if Miss Liberty works as well as FC2. They also checked safety and how much women liked using it.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Miss Liberty female condom (polyurethane device with two flexible rings)

What this could lead to

If successful, this could provide a safe and acceptable alternative female condom option for pregnancy and STI prevention.

What could go wrong

This is a completed device comparison study, not a treatment trial. Results may show no significant difference or lower performance than FC2.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FUNCTIONAL PERFORMANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • MatCH Research Unit [Maternal, Adolescent and Child Health Research Unit]

    Durban, KwaZulu-Natal, 4001, South Africa